Tags

Type your tag names separated by a space and hit enter

A prospective evaluation of the impact of second-opinion histopathology on diagnostic testing, cost and treatment in dogs and cats with cancer.
Vet Comp Oncol. 2015 Jun; 13(2):106-16.VC

Abstract

Second-opinion histopathology is a common practice in human medicine to avoid unnecessary procedures, costs and to optimize therapy. Histopathology review has been recommended in veterinary oncology as well. In this prospective evaluation of 52 tumours over a 1-year period, there was diagnostic agreement between first and second opinions in 52% of cases. Twenty-nine percent of cases had partial diagnostic disagreement, most often a change in grade, tumour subtype or margin status. Nineteen percent had complete diagnostic disagreement, including a change in cell of origin or a change from benign to malignant. Minor disagreements, which would not affect treatment or prognosis, were present in 21% of cases. Major disagreements, which would affect either treatment or prognosis, were present in 37% of cases. Costs of ideal staging and treatment recommendations were considerably different between first and second opinions.

Authors+Show Affiliations

Department of Clinical Sciences, College of VeterinaryMedicine, Cornell University, Ithaca, NY, USA. Department of Small Animal Medicine and Surgery, University of Georgia, Athens, GA, USA.Department of Clinical Sciences, College of VeterinaryMedicine, Cornell University, Ithaca, NY, USA. Department of Oncology, Veterinary Medical Center of Central New York, Syracuse, NY, USA.Department of Clinical Sciences, College of VeterinaryMedicine, Cornell University, Ithaca, NY, USA. Department of Oncology MedVet Medical & Cancer Center for Pets, Columbus, OH, USA.Department of Clinical Sciences, College of VeterinaryMedicine, Cornell University, Ithaca, NY, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

23421645

Citation

Regan, R C., et al. "A Prospective Evaluation of the Impact of Second-opinion Histopathology On Diagnostic Testing, Cost and Treatment in Dogs and Cats With Cancer." Veterinary and Comparative Oncology, vol. 13, no. 2, 2015, pp. 106-16.
Regan RC, Rassnick KM, Malone EK, et al. A prospective evaluation of the impact of second-opinion histopathology on diagnostic testing, cost and treatment in dogs and cats with cancer. Vet Comp Oncol. 2015;13(2):106-16.
Regan, R. C., Rassnick, K. M., Malone, E. K., & McDonough, S. P. (2015). A prospective evaluation of the impact of second-opinion histopathology on diagnostic testing, cost and treatment in dogs and cats with cancer. Veterinary and Comparative Oncology, 13(2), 106-16. https://doi.org/10.1111/vco.12023
Regan RC, et al. A Prospective Evaluation of the Impact of Second-opinion Histopathology On Diagnostic Testing, Cost and Treatment in Dogs and Cats With Cancer. Vet Comp Oncol. 2015;13(2):106-16. PubMed PMID: 23421645.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A prospective evaluation of the impact of second-opinion histopathology on diagnostic testing, cost and treatment in dogs and cats with cancer. AU - Regan,R C, AU - Rassnick,K M, AU - Malone,E K, AU - McDonough,S P, Y1 - 2013/02/19/ PY - 2012/11/16/received PY - 2013/01/20/revised PY - 2013/01/22/accepted PY - 2013/2/21/entrez PY - 2013/2/21/pubmed PY - 2016/1/27/medline KW - oncology KW - pathology KW - second opinion KW - small animal KW - surgical pathology SP - 106 EP - 16 JF - Veterinary and comparative oncology JO - Vet Comp Oncol VL - 13 IS - 2 N2 - Second-opinion histopathology is a common practice in human medicine to avoid unnecessary procedures, costs and to optimize therapy. Histopathology review has been recommended in veterinary oncology as well. In this prospective evaluation of 52 tumours over a 1-year period, there was diagnostic agreement between first and second opinions in 52% of cases. Twenty-nine percent of cases had partial diagnostic disagreement, most often a change in grade, tumour subtype or margin status. Nineteen percent had complete diagnostic disagreement, including a change in cell of origin or a change from benign to malignant. Minor disagreements, which would not affect treatment or prognosis, were present in 21% of cases. Major disagreements, which would affect either treatment or prognosis, were present in 37% of cases. Costs of ideal staging and treatment recommendations were considerably different between first and second opinions. SN - 1476-5829 UR - https://www.unboundmedicine.com/medline/citation/23421645/A_prospective_evaluation_of_the_impact_of_second_opinion_histopathology_on_diagnostic_testing_cost_and_treatment_in_dogs_and_cats_with_cancer_ L2 - https://doi.org/10.1111/vco.12023 DB - PRIME DP - Unbound Medicine ER -